New Releases from NCBI BookshelfBelimumab for treating active autoantibody-positive systemic lupus erythematosus.​Belimumab for treating active autoantibody-positive systemic lupus erythematosus.

Post Content

​ 

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top